Advertisement

Journal of Assisted Reproduction and Genetics

, Volume 32, Issue 3, pp 407–408 | Cite as

Is it time to consider patients suffering from endometriosis-related infertility as “novel candidates” for targeted peri-conceptional D-chiro inositol supplementation? Hypothesis, rationale and some considerations

  • Amerigo Vitagliano
  • Marco Noventa
  • Salvatore Gizzo
Letter to the editor

Dear Editor,

We read with great pleasure the interesting data reported by Piomboni et al. concerning several advantages patients affected by polycystic ovarian syndrome (PCOS) and undergoing controlled ovarian hyperstimulation (COH) with pre-treatment supplementation by D-chiro inositol and/or metformin treatment. [1] The demonstrat D-chiro inositol supplementation and metformin treatment were both shown to significantly improve the follicular fluid (FF) milieu by decreasing the oxidative damage (measured as free-SH groups levels) on FF proteins and, as a consequence, significantly increase the number of good quality MII oocytes.

Although for many years it was known that the oxidative stress could have a negative effects on FF environment, recent evidence has suggested that good quality oocytes require a correct balance in FF pro-oxidative and anti-oxidative factors, [2] since an excess in pro-oxidative status is associated with poor quality oocytes, low fertilization and implantation...

Keywords

Melatonin Endometriosis Follicular Fluid PCOS Patient Metformin Treatment 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Piomboni P, Focarelli R, Capaldo A, Stendardi A, Cappelli V, Cianci A, et al. Protein modification as oxidative stress marker in follicular fluid from women with polycystic ovary syndrome: the effect of inositol and metformin. J Assist Reprod Genet. 2014;31(10):1269–76.PubMedCrossRefGoogle Scholar
  2. 2.
    Gizzo S, Capuzzo D, Zicchina C, Di Gangi S, Coronella ML, Andrisani A, et al. Could empirical low-dose-aspirin administration during IVF cycle affect both the oocytes and embryos quality via COX 1–2 activity inhibition? J Assist Reprod Genet. 2014;31(3):261–8.PubMedCentralPubMedCrossRefGoogle Scholar
  3. 3.
    Jancar N, Kopitar AN, Ihan A, Virant Klun I, Bokal EV. Effect of apoptosis and reactive oxygen species production in human granulosa cells on oocyte fertilization and blastocyst development. J Assist Reprod Genet. 2007;24(2–3):91–7.PubMedCentralPubMedCrossRefGoogle Scholar
  4. 4.
    Hennet ML, Yu HY, Combelles CM. Follicular fluid hydrogen peroxide and lipid hydroperoxide in bovine antral follicles of various size, atresia, and dominance status. J Assist Reprod Genet. 2013;30(3):333–40.PubMedCentralPubMedCrossRefGoogle Scholar
  5. 5.
    Patrelli TS, Berretta R, Gizzo S, Pezzuto A, Franchi L, Lukanovic A, et al. CA 125 serum values in surgically treated endometriosis patients and its relationships with anatomic sites of endometriosis and pregnancy rate. Fertil Steril. 2011;95(1):393–6.PubMedCrossRefGoogle Scholar
  6. 6.
    Choi YS, Cho S, Seo SK, Park JH, Kim SH, Lee BS. Alteration of the intrafollicular thiol-redox system in infertile women with endometriosis. Reproduction. 2014 Nov 5. pii: REP-14-0438.Google Scholar
  7. 7.
    Cohen J, Ziyyat A, Naoura I, Chabbert-Buffet N, Aractingi S, Darai E, Lefevre B. Effect of induced peritoneal endometriosis on oocyte and embryo quality in a mouse model. J Assist Reprod Genet. 2014 Nov 16.Google Scholar
  8. 8.
    McKinnon B, Bertschi D, Wotzkow C, Bersinger NA, Evers J, Mueller MD. Glucose transporter expression in eutopic endometrial tissue and ectopic endometriotic lesions. J Mol Endocrinol. 2014;52(2):169–79.PubMedCrossRefGoogle Scholar
  9. 9.
    Melo AS, Rosa-e-Silva JC, Rosa-e-Silva AC, Poli-Neto OB, Ferriani RA, Vieira CS. Unfavorable lipid profile in women with endometriosis. Fertil Steril. 2010;93(7):2433–6.PubMedCrossRefGoogle Scholar
  10. 10.
    Polak G, Barczyński B, Kwaśniewski W, Bednarek W, Wertel I, Derewianka-Polak M, et al. Low-density lipoproteins oxidation and endometriosis. Mediators Inflamm. 2013;2013:624540.PubMedCentralPubMedGoogle Scholar
  11. 11.
    Nestler JE, Jakubowicz DJ, Reamer P, Gunn RD, Allan G. Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome. N Engl J Med. 1999;340(17):1314–20.PubMedCrossRefGoogle Scholar
  12. 12.
    Larner J, Brautigan DL, Thorner MO. D-chiro-inositol glycans in insulin signaling and insulin resistance. Mol Med. 2010;16(11–12):543–52.PubMedCentralPubMedGoogle Scholar
  13. 13.
    Tamura H, Takasaki A, Nakamura Y, Numa F, Sugino N. A pilot study to search possible mechanisms of ultralong gonadotropin-releasing hormone agonist therapy in IVF-ET patients with endometriosis. J Ovarian Res. 2014;7(1):100.PubMedCentralPubMedCrossRefGoogle Scholar
  14. 14.
    Vitagliano A, Noventa M, Gizzo S. Emerging evidence regarding statins use as novel endometriosis targeted treatment: real “magic pills” or “trendy” drugs? Some considerations. Eur J Obstet Gynecol Reprod Biol. 2014, In Press. (http://dx.doi.org/ 10.1016/j.ejogrb.2014.11.018)

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Amerigo Vitagliano
    • 1
  • Marco Noventa
    • 1
  • Salvatore Gizzo
    • 1
  1. 1.Department of Woman and Child HealthUniversity of PaduaPaduaItaly

Personalised recommendations